Remove 2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE malware
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE Malware Removal Guide
Manual removal instructions:
Antivirus Report of 2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE:
2d417931-f0d4-4b0c-a9ed-a91915ad1ddd-64.exe
We suggest you to remove 2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE from your computer as soon as possible.
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE is known as: Cinema-Plus-1.2V28.09 exe
Antivirus testing: 10 / 68
Dangerous Status: Adware
Malware Aliases: Win-PUP/CrossRider ADWARE/CrossRider.Gen7 Generic PUA.Win64.Crossrider ApplicUnwnt.
MD5 of 2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE = B7F1D1C373D98EB20854A59428FCBB35
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE size is 1718680 bytes.
Full path on a computer: C:\PROGRAM FILES\CINEMA-PLUS-1.2V28.09\2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE | Cinema-Plus-1.2V28.09 exe Antivirus testing: 10 / 68 Dangerous Status: Adware Malware Aliases: Win-PUP/CrossRider ADWARE/CrossRider.Gen7 Generic PUA.Win64.Crossrider ApplicUnwnt. |
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE | Dangerous |
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE | High Risk |
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE is known as: Cinema-Plus-1.2V28.09 exe
Antivirus testing: 10 / 68
Dangerous Status: Adware
Malware Aliases: Win-PUP/CrossRider ADWARE/CrossRider.Gen7 Generic PUA.Win64.Crossrider ApplicUnwnt.
MD5 of 2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE = B7F1D1C373D98EB20854A59428FCBB35
2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE size is 1718680 bytes.
Full path on a computer: C:\PROGRAM FILES\CINEMA-PLUS-1.2V28.09\2D417931-F0D4-4B0C-A9ED-A91915AD1DDD-64.EXE
Dmitry Sokolov:
I created UnHackMe in 2006 to fix the problem that antivioruses did not fix: detecting rootkits.
Since that time I work every day to fix the issues that antiviruses cannot.
If your antivirus have not helped you solve the problem, you should try UnHackMe.
We are a small company and you can ask me directly, if you have any questions.